Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710

NCT02756637 · clinicaltrials.gov ↗
COMPLETED
Status
634
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Abramson Cancer Center at Penn Medicine